MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Hepatocellular carcinoma (HCC) is a prevalent cancer with limited treatment options.
• Radioresistance in HCC cells poses a significant challenge to effective radiotherapy.
• Understanding the molecular mechanisms underlying HCC radioresistance is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To investigate the role of microRNA-20a (miR-20a) in hepatocellular carcinoma (HCC) cell radioresistance.
• To identify potential therapeutic targets for overcoming HCC radioresistance.

Main Methods:

• Quantitative real-time polymerase chain reaction (qRT-PCR) to detect miR-20a and PTEN expression in HCC cell lines and tissues.
• Cell viability assays (colony formation assays) to assess the impact of miR-20a on radiosensitivity.
• Bioinformatics prediction and luciferase assays to identify miR-20a targets.
• Inhibition of the PI3K/Akt pathway using LY294002 to validate the signaling mechanism.

Main Results:

• MiR-20a expression was elevated in HCC cells and tissues, inversely correlated with PTEN expression.
• Overexpression of miR-20a enhanced radioresistance in HCC cells, while its inhibition sensitized cells to radiation.
• PTEN was identified as a direct target of miR-20a, and miR-20a activation of the PTEN/PI3K/Akt pathway was confirmed.
• Inhibition of the PI3K/Akt pathway reversed miR-20a-induced radioresistance.

Conclusions:

• MiR-20a promotes radioresistance in hepatocellular carcinoma cells by activating the PTEN/PI3K/Akt signaling pathway.
• The miR-20a/PTEN/PI3K/Akt axis represents a promising therapeutic target for enhancing HCC treatment efficacy.